Sonendo, Inc. (SONX) company profile
Close on Oct 19, 2026Market cap $606.54KP/E –Yield –
About Sonendo
Dental Equipment & Supplies, SIC 3843
Sonendo, Inc. is a commercial-stage medical technology company that develops and manufactures medical devices designed to treat tooth decay and preserve tooth structure. Its principal offering is the GentleWave System, an FDA-cleared console and single-use procedure instrument platform that utilizes fluid optimization, broad-spectrum acoustic energy, and fluid dynamics for root canal therapy. The company operates through its Product segment, providing consoles and related accessories to dental practitioners, while having divested its Software practice management segment.
The company is based in the United States and maintains its principal executive offices in Laguna Hills, California. Sonendo focuses on treating tooth decay globally and holds an intellectual property portfolio comprising 141 issued patents and 49 pending patent applications to support its operations and proprietary mechanism of action.
Summary of the business section of Sonendo's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Sonendo, Inc.
- Founded
- 2006
- Headquarters
- Laguna Hills, CA
- Address
- 26061 Merit Circle, Suite 101 92653
- Phone
- (949) 766-3636
- Website
- sonendo.com
- Employees
- 131, Dec 31, 2024
- Industry
- Dental Equipment & Supplies
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, Irvine, California
Stock & identifiers
- Ticker
- SONX
- Exchange
- OTC
- IPO date
- Nov 1, 2021
- Shares outstanding
- 0M, Mar 12, 2025
- Public float
- $4.30M, Jun 30, 2024
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Stock splits
- 1-for-200 reverse, Nov 8, 2024
- SEC CIK
- 1407973
- FIGI
- BBG002082QR8
- Share class FIGI
- BBG002082QS7
- EIN
- 20-5041718
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Sonendo's leadership is listed in its proxy statement, last filed Apr 29, 2024.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Nov 1, 2021
- Offer price
- $12.00
- Securities offered
- 7,800,000
- Gross proceeds
- $93.60M
- Exchange
- NYSE
- First trading day
- Oct 29, 2021
- First-day close
- $9.20-23.3%
- Lock-up ends (est.)
- Apr 27, 2022
“The public offering price is $12.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2024, we had 131 employees (including 129 full-time employees).”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Feb 27, 2025 | Deregistration | Termination of SEC registration (Form 15) |
| Oct 2, 2024 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Aug 16, 2024 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Apr 15, 2024 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Apr 11, 2024 | Delisting | Notice of delisting from exchange (Form 25) |
| Mar 5, 2024 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Nov 21, 2023 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Oct 2, 2023 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Nov 1, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Oct 28, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |
| Dec 1, 2010 | Name change | Name changed from Dentatek CORP to Sonendo, Inc. |
See a number that looks wrong?